nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—SLC22A3—Progesterone—uterine cancer	0.0968	0.145	CbGbCtD
Lamivudine—ABCC1—Progesterone—uterine cancer	0.0632	0.095	CbGbCtD
Lamivudine—SLC22A2—Progesterone—uterine cancer	0.0573	0.0861	CbGbCtD
Lamivudine—ABCC1—Dactinomycin—uterine cancer	0.0501	0.0753	CbGbCtD
Lamivudine—SLC22A1—Progesterone—uterine cancer	0.0498	0.0748	CbGbCtD
Lamivudine—ABCC3—Etoposide—uterine cancer	0.0461	0.0692	CbGbCtD
Lamivudine—ABCC1—Epirubicin—uterine cancer	0.0363	0.0545	CbGbCtD
Lamivudine—ABCG2—Dactinomycin—uterine cancer	0.0335	0.0504	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—uterine cancer	0.0314	0.0472	CbGbCtD
Lamivudine—ABCC1—Etoposide—uterine cancer	0.0283	0.0425	CbGbCtD
Lamivudine—ABCC2—Carboplatin—uterine cancer	0.0249	0.0375	CbGbCtD
Lamivudine—ABCG2—Carboplatin—uterine cancer	0.0225	0.0339	CbGbCtD
Lamivudine—ABCC2—Etoposide—uterine cancer	0.0209	0.0315	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—uterine cancer	0.0193	0.029	CbGbCtD
Lamivudine—ABCG2—Etoposide—uterine cancer	0.0189	0.0284	CbGbCtD
Lamivudine—ABCB1—Progesterone—uterine cancer	0.0152	0.0229	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—uterine cancer	0.0143	0.0215	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—uterine cancer	0.0129	0.0194	CbGbCtD
Lamivudine—ABCB1—Dactinomycin—uterine cancer	0.0121	0.0182	CbGbCtD
Lamivudine—ABCB1—Etoposide—uterine cancer	0.00682	0.0103	CbGbCtD
Lamivudine—ABCB1—Doxorubicin—uterine cancer	0.00465	0.00699	CbGbCtD
Lamivudine—Gemcitabine—POLD1—uterine cancer	0.00374	0.481	CrCbGaD
Lamivudine—PCYT2—renal system—uterine cancer	0.00362	0.0406	CbGeAlD
Lamivudine—PCYT2—female reproductive system—uterine cancer	0.0029	0.0325	CbGeAlD
Lamivudine—PGK1—uterus—uterine cancer	0.00277	0.031	CbGeAlD
Lamivudine—NT5C—renal system—uterine cancer	0.00263	0.0294	CbGeAlD
Lamivudine—Cytarabine—POLD1—uterine cancer	0.00255	0.328	CrCbGaD
Lamivudine—PGK1—female reproductive system—uterine cancer	0.00249	0.0279	CbGeAlD
Lamivudine—PCYT1A—renal system—uterine cancer	0.00246	0.0276	CbGeAlD
Lamivudine—NT5C—uterus—uterine cancer	0.00234	0.0262	CbGeAlD
Lamivudine—NME1-NME2—female reproductive system—uterine cancer	0.00227	0.0254	CbGeAlD
Lamivudine—NT5C—female reproductive system—uterine cancer	0.0021	0.0236	CbGeAlD
Lamivudine—PCYT1A—female reproductive system—uterine cancer	0.00197	0.0221	CbGeAlD
Lamivudine—NT5C—female gonad—uterine cancer	0.00191	0.0214	CbGeAlD
Lamivudine—NT5C—vagina—uterine cancer	0.0019	0.0213	CbGeAlD
Lamivudine—CMPK1—uterine cervix—uterine cancer	0.0017	0.019	CbGeAlD
Lamivudine—NME2—epithelium—uterine cancer	0.00167	0.0187	CbGeAlD
Lamivudine—CMPK1—smooth muscle tissue—uterine cancer	0.00165	0.0185	CbGeAlD
Lamivudine—NME1—renal system—uterine cancer	0.00165	0.0185	CbGeAlD
Lamivudine—CMPK1—decidua—uterine cancer	0.00162	0.0181	CbGeAlD
Lamivudine—CMPK1—renal system—uterine cancer	0.00159	0.0178	CbGeAlD
Lamivudine—NME2—renal system—uterine cancer	0.00155	0.0174	CbGeAlD
Lamivudine—Gemcitabine—RRM2—uterine cancer	0.00149	0.191	CrCbGaD
Lamivudine—NME1—uterus—uterine cancer	0.00147	0.0164	CbGeAlD
Lamivudine—CMPK1—uterus—uterine cancer	0.00141	0.0159	CbGeAlD
Lamivudine—NME1-NME2—lymph node—uterine cancer	0.00133	0.0149	CbGeAlD
Lamivudine—NME1—female reproductive system—uterine cancer	0.00132	0.0148	CbGeAlD
Lamivudine—CMPK1—female reproductive system—uterine cancer	0.00127	0.0142	CbGeAlD
Lamivudine—NME2—female reproductive system—uterine cancer	0.00124	0.0139	CbGeAlD
Lamivudine—NT5C—lymph node—uterine cancer	0.00123	0.0138	CbGeAlD
Lamivudine—NME1—female gonad—uterine cancer	0.0012	0.0135	CbGeAlD
Lamivudine—CMPK1—female gonad—uterine cancer	0.00116	0.013	CbGeAlD
Lamivudine—CMPK1—vagina—uterine cancer	0.00115	0.0129	CbGeAlD
Lamivudine—NME2—female gonad—uterine cancer	0.00113	0.0127	CbGeAlD
Lamivudine—DCK—myometrium—uterine cancer	0.00109	0.0122	CbGeAlD
Lamivudine—SLC22A2—renal system—uterine cancer	0.000955	0.0107	CbGeAlD
Lamivudine—SLC22A3—myometrium—uterine cancer	0.000885	0.00992	CbGeAlD
Lamivudine—DCK—uterine cervix—uterine cancer	0.000845	0.00947	CbGeAlD
Lamivudine—DCK—decidua—uterine cancer	0.000805	0.00902	CbGeAlD
Lamivudine—NME1—lymph node—uterine cancer	0.000772	0.00865	CbGeAlD
Lamivudine—ABCC3—decidua—uterine cancer	0.000771	0.00864	CbGeAlD
Lamivudine—DCK—endometrium—uterine cancer	0.000764	0.00856	CbGeAlD
Lamivudine—ABCC3—renal system—uterine cancer	0.000757	0.00848	CbGeAlD
Lamivudine—CMPK1—lymph node—uterine cancer	0.000744	0.00834	CbGeAlD
Lamivudine—DCK—mammalian vulva—uterine cancer	0.000739	0.00828	CbGeAlD
Lamivudine—ABCC1—myometrium—uterine cancer	0.000732	0.0082	CbGeAlD
Lamivudine—NME2—lymph node—uterine cancer	0.000727	0.00815	CbGeAlD
Lamivudine—DCK—uterus—uterine cancer	0.000704	0.00789	CbGeAlD
Lamivudine—NME1—Levonorgestrel—Progesterone—uterine cancer	0.000693	0.283	CbGdCrCtD
Lamivudine—SLC22A3—uterine cervix—uterine cancer	0.000689	0.00772	CbGeAlD
Lamivudine—SLC22A1—renal system—uterine cancer	0.000674	0.00756	CbGeAlD
Lamivudine—SLC22A3—smooth muscle tissue—uterine cancer	0.000669	0.0075	CbGeAlD
Lamivudine—DCK—Doxorubicin—Epirubicin—uterine cancer	0.000667	0.272	CbGdCrCtD
Lamivudine—SLC22A3—renal system—uterine cancer	0.000644	0.00722	CbGeAlD
Lamivudine—DCK—female reproductive system—uterine cancer	0.000633	0.0071	CbGeAlD
Lamivudine—ABCC4—renal system—uterine cancer	0.000625	0.007	CbGeAlD
Lamivudine—SLC22A3—endometrium—uterine cancer	0.000623	0.00698	CbGeAlD
Lamivudine—DCK—Epirubicin—Doxorubicin—uterine cancer	0.000617	0.252	CbGdCrCtD
Lamivudine—ABCC3—female reproductive system—uterine cancer	0.000606	0.00679	CbGeAlD
Lamivudine—ABCG2—myometrium—uterine cancer	0.000606	0.00679	CbGeAlD
Lamivudine—ABCC2—renal system—uterine cancer	0.000605	0.00678	CbGeAlD
Lamivudine—SLC22A3—mammalian vulva—uterine cancer	0.000603	0.00675	CbGeAlD
Lamivudine—DCK—female gonad—uterine cancer	0.000576	0.00646	CbGeAlD
Lamivudine—DCK—vagina—uterine cancer	0.000573	0.00642	CbGeAlD
Lamivudine—ABCC1—uterine cervix—uterine cancer	0.000569	0.00638	CbGeAlD
Lamivudine—ABCC4—uterus—uterine cancer	0.000557	0.00624	CbGeAlD
Lamivudine—ABCC3—female gonad—uterine cancer	0.000552	0.00618	CbGeAlD
Lamivudine—ABCC1—decidua—uterine cancer	0.000543	0.00608	CbGeAlD
Lamivudine—SLC22A3—female reproductive system—uterine cancer	0.000516	0.00578	CbGeAlD
Lamivudine—ABCC1—endometrium—uterine cancer	0.000515	0.00577	CbGeAlD
Lamivudine—ABCC4—female reproductive system—uterine cancer	0.0005	0.00561	CbGeAlD
Lamivudine—ABCC1—mammalian vulva—uterine cancer	0.000498	0.00558	CbGeAlD
Lamivudine—SLC22A1—vagina—uterine cancer	0.000488	0.00547	CbGeAlD
Lamivudine—ABCC2—female reproductive system—uterine cancer	0.000484	0.00543	CbGeAlD
Lamivudine—ABCC1—uterus—uterine cancer	0.000475	0.00532	CbGeAlD
Lamivudine—DCK—Levonorgestrel—Progesterone—uterine cancer	0.000472	0.193	CbGdCrCtD
Lamivudine—ABCG2—uterine cervix—uterine cancer	0.000471	0.00528	CbGeAlD
Lamivudine—SLC22A3—female gonad—uterine cancer	0.00047	0.00526	CbGeAlD
Lamivudine—SLC22A3—vagina—uterine cancer	0.000467	0.00523	CbGeAlD
Lamivudine—ABCC4—female gonad—uterine cancer	0.000455	0.0051	CbGeAlD
Lamivudine—ABCG2—decidua—uterine cancer	0.000449	0.00503	CbGeAlD
Lamivudine—ABCG2—endometrium—uterine cancer	0.000426	0.00478	CbGeAlD
Lamivudine—ABCG2—mammalian vulva—uterine cancer	0.000412	0.00462	CbGeAlD
Lamivudine—ABCG2—uterus—uterine cancer	0.000393	0.0044	CbGeAlD
Lamivudine—ABCC1—female gonad—uterine cancer	0.000388	0.00435	CbGeAlD
Lamivudine—ABCC1—vagina—uterine cancer	0.000386	0.00432	CbGeAlD
Lamivudine—DCK—lymph node—uterine cancer	0.00037	0.00415	CbGeAlD
Lamivudine—ABCC3—lymph node—uterine cancer	0.000355	0.00397	CbGeAlD
Lamivudine—ABCG2—female gonad—uterine cancer	0.000321	0.0036	CbGeAlD
Lamivudine—ABCG2—vagina—uterine cancer	0.000319	0.00358	CbGeAlD
Lamivudine—SLC22A3—lymph node—uterine cancer	0.000302	0.00338	CbGeAlD
Lamivudine—ABCB1—myometrium—uterine cancer	0.000299	0.00335	CbGeAlD
Lamivudine—ABCC4—lymph node—uterine cancer	0.000293	0.00328	CbGeAlD
Lamivudine—ABCC2—lymph node—uterine cancer	0.000283	0.00318	CbGeAlD
Lamivudine—ABCC1—lymph node—uterine cancer	0.00025	0.0028	CbGeAlD
Lamivudine—ABCB1—epithelium—uterine cancer	0.000234	0.00263	CbGeAlD
Lamivudine—ABCB1—uterine cervix—uterine cancer	0.000232	0.00261	CbGeAlD
Lamivudine—ABCB1—decidua—uterine cancer	0.000221	0.00248	CbGeAlD
Lamivudine—ABCB1—renal system—uterine cancer	0.000217	0.00244	CbGeAlD
Lamivudine—ABCB1—endometrium—uterine cancer	0.00021	0.00236	CbGeAlD
Lamivudine—ABCG2—lymph node—uterine cancer	0.000207	0.00232	CbGeAlD
Lamivudine—ABCB1—mammalian vulva—uterine cancer	0.000203	0.00228	CbGeAlD
Lamivudine—ABCB1—uterus—uterine cancer	0.000194	0.00217	CbGeAlD
Lamivudine—ABCB1—female reproductive system—uterine cancer	0.000174	0.00195	CbGeAlD
Lamivudine—ABCB1—female gonad—uterine cancer	0.000158	0.00178	CbGeAlD
Lamivudine—ABCB1—vagina—uterine cancer	0.000158	0.00177	CbGeAlD
Lamivudine—Malaise—Etoposide—uterine cancer	0.000157	0.00102	CcSEcCtD
Lamivudine—Vertigo—Etoposide—uterine cancer	0.000156	0.00102	CcSEcCtD
Lamivudine—Leukopenia—Etoposide—uterine cancer	0.000156	0.00101	CcSEcCtD
Lamivudine—Abdominal pain—Dactinomycin—uterine cancer	0.000155	0.00101	CcSEcCtD
Lamivudine—Body temperature increased—Dactinomycin—uterine cancer	0.000155	0.00101	CcSEcCtD
Lamivudine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000154	0.000998	CcSEcCtD
Lamivudine—Mood swings—Epirubicin—uterine cancer	0.000153	0.000998	CcSEcCtD
Lamivudine—Loss of consciousness—Etoposide—uterine cancer	0.000153	0.000994	CcSEcCtD
Lamivudine—Cough—Etoposide—uterine cancer	0.000152	0.000987	CcSEcCtD
Lamivudine—Convulsion—Etoposide—uterine cancer	0.000151	0.00098	CcSEcCtD
Lamivudine—Dehydration—Epirubicin—uterine cancer	0.000151	0.000979	CcSEcCtD
Lamivudine—Liver function test abnormal—Epirubicin—uterine cancer	0.00015	0.000972	CcSEcCtD
Lamivudine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000149	0.000972	CcSEcCtD
Lamivudine—Chest pain—Etoposide—uterine cancer	0.000148	0.000963	CcSEcCtD
Lamivudine—Abdominal pain upper—Epirubicin—uterine cancer	0.000148	0.000962	CcSEcCtD
Lamivudine—Affect lability—Doxorubicin—uterine cancer	0.000147	0.000959	CcSEcCtD
Lamivudine—Migraine—Doxorubicin—uterine cancer	0.000147	0.000959	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000147	0.000957	CcSEcCtD
Lamivudine—Discomfort—Etoposide—uterine cancer	0.000146	0.000952	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000146	0.000948	CcSEcCtD
Lamivudine—Nasopharyngitis—Epirubicin—uterine cancer	0.000145	0.000942	CcSEcCtD
Lamivudine—Hypersensitivity—Dactinomycin—uterine cancer	0.000145	0.00094	CcSEcCtD
Lamivudine—Confusional state—Etoposide—uterine cancer	0.000143	0.000931	CcSEcCtD
Lamivudine—Muscular weakness—Epirubicin—uterine cancer	0.000143	0.000929	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000143	0.000929	CcSEcCtD
Lamivudine—Anaphylactic shock—Etoposide—uterine cancer	0.000142	0.000923	CcSEcCtD
Lamivudine—Mood swings—Doxorubicin—uterine cancer	0.000142	0.000923	CcSEcCtD
Lamivudine—Infection—Etoposide—uterine cancer	0.000141	0.000917	CcSEcCtD
Lamivudine—Abdominal distension—Epirubicin—uterine cancer	0.000141	0.000916	CcSEcCtD
Lamivudine—Asthenia—Dactinomycin—uterine cancer	0.000141	0.000915	CcSEcCtD
Lamivudine—Influenza—Epirubicin—uterine cancer	0.00014	0.00091	CcSEcCtD
Lamivudine—Dysphagia—Epirubicin—uterine cancer	0.00014	0.00091	CcSEcCtD
Lamivudine—Dehydration—Doxorubicin—uterine cancer	0.000139	0.000906	CcSEcCtD
Lamivudine—Thrombocytopenia—Etoposide—uterine cancer	0.000139	0.000904	CcSEcCtD
Lamivudine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000138	0.0009	CcSEcCtD
Lamivudine—Skin disorder—Etoposide—uterine cancer	0.000138	0.000897	CcSEcCtD
Lamivudine—Hyperhidrosis—Etoposide—uterine cancer	0.000137	0.000893	CcSEcCtD
Lamivudine—Pancreatitis—Epirubicin—uterine cancer	0.000137	0.000892	CcSEcCtD
Lamivudine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000137	0.00089	CcSEcCtD
Lamivudine—Anorexia—Etoposide—uterine cancer	0.000135	0.00088	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000135	0.000877	CcSEcCtD
Lamivudine—Bronchitis—Epirubicin—uterine cancer	0.000135	0.000875	CcSEcCtD
Lamivudine—Diarrhoea—Dactinomycin—uterine cancer	0.000134	0.000873	CcSEcCtD
Lamivudine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000134	0.000871	CcSEcCtD
Lamivudine—Pancytopenia—Epirubicin—uterine cancer	0.000133	0.000864	CcSEcCtD
Lamivudine—Hypotension—Etoposide—uterine cancer	0.000133	0.000863	CcSEcCtD
Lamivudine—Muscular weakness—Doxorubicin—uterine cancer	0.000132	0.000859	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000132	0.000859	CcSEcCtD
Lamivudine—Dysuria—Epirubicin—uterine cancer	0.000131	0.000851	CcSEcCtD
Lamivudine—Neutropenia—Epirubicin—uterine cancer	0.000131	0.000851	CcSEcCtD
Lamivudine—Abdominal distension—Doxorubicin—uterine cancer	0.00013	0.000848	CcSEcCtD
Lamivudine—Influenza—Doxorubicin—uterine cancer	0.00013	0.000842	CcSEcCtD
Lamivudine—Dysphagia—Doxorubicin—uterine cancer	0.00013	0.000842	CcSEcCtD
Lamivudine—Pollakiuria—Epirubicin—uterine cancer	0.000129	0.000841	CcSEcCtD
Lamivudine—Paraesthesia—Etoposide—uterine cancer	0.000127	0.000829	CcSEcCtD
Lamivudine—Pancreatitis—Doxorubicin—uterine cancer	0.000127	0.000826	CcSEcCtD
Lamivudine—Dyspnoea—Etoposide—uterine cancer	0.000127	0.000823	CcSEcCtD
Lamivudine—Hyperglycaemia—Epirubicin—uterine cancer	0.000126	0.000821	CcSEcCtD
Lamivudine—Somnolence—Etoposide—uterine cancer	0.000126	0.000821	CcSEcCtD
Lamivudine—Vomiting—Dactinomycin—uterine cancer	0.000125	0.000811	CcSEcCtD
Lamivudine—Bronchitis—Doxorubicin—uterine cancer	0.000125	0.00081	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000124	0.000805	CcSEcCtD
Lamivudine—Rash—Dactinomycin—uterine cancer	0.000124	0.000804	CcSEcCtD
Lamivudine—Decreased appetite—Etoposide—uterine cancer	0.000123	0.000803	CcSEcCtD
Lamivudine—Pancytopenia—Doxorubicin—uterine cancer	0.000123	0.0008	CcSEcCtD
Lamivudine—Renal failure—Epirubicin—uterine cancer	0.000123	0.000798	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000123	0.000797	CcSEcCtD
Lamivudine—Fatigue—Etoposide—uterine cancer	0.000122	0.000796	CcSEcCtD
Lamivudine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000122	0.000796	CcSEcCtD
Lamivudine—Stomatitis—Epirubicin—uterine cancer	0.000122	0.000791	CcSEcCtD
Lamivudine—Jaundice—Epirubicin—uterine cancer	0.000122	0.000791	CcSEcCtD
Lamivudine—Pain—Etoposide—uterine cancer	0.000121	0.00079	CcSEcCtD
Lamivudine—Constipation—Etoposide—uterine cancer	0.000121	0.00079	CcSEcCtD
Lamivudine—Neutropenia—Doxorubicin—uterine cancer	0.000121	0.000788	CcSEcCtD
Lamivudine—Dysuria—Doxorubicin—uterine cancer	0.000121	0.000788	CcSEcCtD
Lamivudine—Sweating—Epirubicin—uterine cancer	0.00012	0.000778	CcSEcCtD
Lamivudine—Pollakiuria—Doxorubicin—uterine cancer	0.00012	0.000778	CcSEcCtD
Lamivudine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000118	0.000768	CcSEcCtD
Lamivudine—Epistaxis—Epirubicin—uterine cancer	0.000118	0.000765	CcSEcCtD
Lamivudine—Sinusitis—Epirubicin—uterine cancer	0.000117	0.000761	CcSEcCtD
Lamivudine—Feeling abnormal—Etoposide—uterine cancer	0.000117	0.000761	CcSEcCtD
Lamivudine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000117	0.00076	CcSEcCtD
Lamivudine—Nausea—Dactinomycin—uterine cancer	0.000117	0.000758	CcSEcCtD
Lamivudine—Agranulocytosis—Epirubicin—uterine cancer	0.000116	0.000757	CcSEcCtD
Lamivudine—Gastrointestinal pain—Etoposide—uterine cancer	0.000116	0.000755	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000114	0.000744	CcSEcCtD
Lamivudine—Renal failure—Doxorubicin—uterine cancer	0.000114	0.000738	CcSEcCtD
Lamivudine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000113	0.000736	CcSEcCtD
Lamivudine—Urticaria—Etoposide—uterine cancer	0.000113	0.000734	CcSEcCtD
Lamivudine—Stomatitis—Doxorubicin—uterine cancer	0.000113	0.000732	CcSEcCtD
Lamivudine—Jaundice—Doxorubicin—uterine cancer	0.000113	0.000732	CcSEcCtD
Lamivudine—Rhinitis—Epirubicin—uterine cancer	0.000112	0.00073	CcSEcCtD
Lamivudine—Body temperature increased—Etoposide—uterine cancer	0.000112	0.00073	CcSEcCtD
Lamivudine—Abdominal pain—Etoposide—uterine cancer	0.000112	0.00073	CcSEcCtD
Lamivudine—Hepatitis—Epirubicin—uterine cancer	0.000112	0.000729	CcSEcCtD
Lamivudine—Hypoaesthesia—Epirubicin—uterine cancer	0.000111	0.000725	CcSEcCtD
Lamivudine—Pharyngitis—Epirubicin—uterine cancer	0.000111	0.000723	CcSEcCtD
Lamivudine—Sweating—Doxorubicin—uterine cancer	0.000111	0.00072	CcSEcCtD
Lamivudine—Connective tissue disorder—Epirubicin—uterine cancer	0.00011	0.000716	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000109	0.00071	CcSEcCtD
Lamivudine—Epistaxis—Doxorubicin—uterine cancer	0.000109	0.000708	CcSEcCtD
Lamivudine—Sinusitis—Doxorubicin—uterine cancer	0.000108	0.000705	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—uterine cancer	0.000108	0.000701	CcSEcCtD
Lamivudine—Erythema multiforme—Epirubicin—uterine cancer	0.000106	0.000689	CcSEcCtD
Lamivudine—Hypersensitivity—Etoposide—uterine cancer	0.000105	0.00068	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—uterine cancer	0.000104	0.000676	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—uterine cancer	0.000104	0.000674	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000103	0.000671	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—uterine cancer	0.000103	0.000669	CcSEcCtD
Lamivudine—ABCB1—lymph node—uterine cancer	0.000102	0.00114	CbGeAlD
Lamivudine—Asthenia—Etoposide—uterine cancer	0.000102	0.000663	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000102	0.000662	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—uterine cancer	0.000101	0.000658	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—uterine cancer	0.000101	0.000657	CcSEcCtD
Lamivudine—Chills—Epirubicin—uterine cancer	0.000101	0.000654	CcSEcCtD
Lamivudine—Pruritus—Etoposide—uterine cancer	0.0001	0.000653	CcSEcCtD
Lamivudine—Alopecia—Epirubicin—uterine cancer	9.9e-05	0.000644	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—uterine cancer	9.8e-05	0.000637	CcSEcCtD
Lamivudine—Erythema—Epirubicin—uterine cancer	9.75e-05	0.000634	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—uterine cancer	9.75e-05	0.000634	CcSEcCtD
Lamivudine—Diarrhoea—Etoposide—uterine cancer	9.72e-05	0.000632	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—uterine cancer	9.61e-05	0.000625	CcSEcCtD
Lamivudine—Tension—Epirubicin—uterine cancer	9.57e-05	0.000622	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—uterine cancer	9.55e-05	0.000621	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—uterine cancer	9.47e-05	0.000616	CcSEcCtD
Lamivudine—Back pain—Epirubicin—uterine cancer	9.43e-05	0.000613	CcSEcCtD
Lamivudine—Dizziness—Etoposide—uterine cancer	9.39e-05	0.000611	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—uterine cancer	9.38e-05	0.00061	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—uterine cancer	9.36e-05	0.000609	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—uterine cancer	9.34e-05	0.000608	CcSEcCtD
Lamivudine—Chills—Doxorubicin—uterine cancer	9.3e-05	0.000605	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—uterine cancer	9.16e-05	0.000596	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—uterine cancer	9.05e-05	0.000588	CcSEcCtD
Lamivudine—Vomiting—Etoposide—uterine cancer	9.03e-05	0.000587	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—uterine cancer	9.02e-05	0.000587	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—uterine cancer	9.02e-05	0.000587	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—uterine cancer	9.01e-05	0.000586	CcSEcCtD
Lamivudine—Rash—Etoposide—uterine cancer	8.95e-05	0.000582	CcSEcCtD
Lamivudine—Dermatitis—Etoposide—uterine cancer	8.94e-05	0.000582	CcSEcCtD
Lamivudine—Headache—Etoposide—uterine cancer	8.9e-05	0.000578	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—uterine cancer	8.89e-05	0.000578	CcSEcCtD
Lamivudine—Tension—Doxorubicin—uterine cancer	8.85e-05	0.000576	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—uterine cancer	8.84e-05	0.000575	CcSEcCtD
Lamivudine—Malaise—Epirubicin—uterine cancer	8.79e-05	0.000572	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—uterine cancer	8.76e-05	0.00057	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—uterine cancer	8.76e-05	0.00057	CcSEcCtD
Lamivudine—Syncope—Epirubicin—uterine cancer	8.75e-05	0.000569	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—uterine cancer	8.73e-05	0.000568	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—uterine cancer	8.73e-05	0.000568	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—uterine cancer	8.68e-05	0.000564	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—uterine cancer	8.57e-05	0.000557	CcSEcCtD
Lamivudine—Cough—Epirubicin—uterine cancer	8.51e-05	0.000553	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—uterine cancer	8.45e-05	0.00055	CcSEcCtD
Lamivudine—Nausea—Etoposide—uterine cancer	8.43e-05	0.000548	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—uterine cancer	8.37e-05	0.000544	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—uterine cancer	8.34e-05	0.000542	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—uterine cancer	8.3e-05	0.00054	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—uterine cancer	8.3e-05	0.00054	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—uterine cancer	8.3e-05	0.00054	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—uterine cancer	8.27e-05	0.000538	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	8.25e-05	0.000536	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—uterine cancer	8.2e-05	0.000533	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—uterine cancer	8.14e-05	0.000529	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—uterine cancer	8.12e-05	0.000528	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—uterine cancer	8.11e-05	0.000527	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—uterine cancer	8.09e-05	0.000526	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—uterine cancer	8.08e-05	0.000525	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—uterine cancer	8.03e-05	0.000522	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—uterine cancer	7.96e-05	0.000518	CcSEcCtD
Lamivudine—Oedema—Epirubicin—uterine cancer	7.96e-05	0.000518	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—uterine cancer	7.93e-05	0.000516	CcSEcCtD
Lamivudine—Infection—Epirubicin—uterine cancer	7.91e-05	0.000514	CcSEcCtD
Lamivudine—Cough—Doxorubicin—uterine cancer	7.87e-05	0.000512	CcSEcCtD
Lamivudine—Shock—Epirubicin—uterine cancer	7.83e-05	0.000509	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—uterine cancer	7.82e-05	0.000508	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—uterine cancer	7.81e-05	0.000508	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—uterine cancer	7.79e-05	0.000507	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—uterine cancer	7.73e-05	0.000503	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—uterine cancer	7.69e-05	0.0005	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—uterine cancer	7.68e-05	0.0005	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—uterine cancer	7.68e-05	0.0005	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—uterine cancer	7.68e-05	0.0005	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—uterine cancer	7.66e-05	0.000498	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	7.63e-05	0.000496	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—uterine cancer	7.59e-05	0.000494	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—uterine cancer	7.59e-05	0.000493	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—uterine cancer	7.51e-05	0.000489	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—uterine cancer	7.44e-05	0.000484	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—uterine cancer	7.43e-05	0.000483	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—uterine cancer	7.36e-05	0.000479	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—uterine cancer	7.36e-05	0.000479	CcSEcCtD
Lamivudine—Infection—Doxorubicin—uterine cancer	7.32e-05	0.000476	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—uterine cancer	7.25e-05	0.000472	CcSEcCtD
Lamivudine—Shock—Doxorubicin—uterine cancer	7.25e-05	0.000471	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—uterine cancer	7.22e-05	0.00047	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—uterine cancer	7.21e-05	0.000469	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—uterine cancer	7.2e-05	0.000468	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—uterine cancer	7.15e-05	0.000465	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—uterine cancer	7.15e-05	0.000465	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—uterine cancer	7.12e-05	0.000463	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—uterine cancer	7.1e-05	0.000461	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—uterine cancer	7.08e-05	0.00046	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—uterine cancer	7.02e-05	0.000457	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—uterine cancer	7.01e-05	0.000456	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—uterine cancer	6.92e-05	0.00045	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—uterine cancer	6.88e-05	0.000448	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—uterine cancer	6.87e-05	0.000447	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—uterine cancer	6.86e-05	0.000446	CcSEcCtD
Lamivudine—Constipation—Epirubicin—uterine cancer	6.81e-05	0.000443	CcSEcCtD
Lamivudine—Pain—Epirubicin—uterine cancer	6.81e-05	0.000443	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.71e-05	0.000436	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—uterine cancer	6.66e-05	0.000433	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—uterine cancer	6.61e-05	0.00043	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—uterine cancer	6.57e-05	0.000427	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—uterine cancer	6.56e-05	0.000427	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—uterine cancer	6.55e-05	0.000426	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—uterine cancer	6.51e-05	0.000423	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—uterine cancer	6.48e-05	0.000422	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—uterine cancer	6.4e-05	0.000416	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—uterine cancer	6.36e-05	0.000413	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—uterine cancer	6.35e-05	0.000413	CcSEcCtD
Lamivudine—ABCC3—Metabolism—NDUFB11—uterine cancer	6.33e-05	0.000779	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SRD5A2—uterine cancer	6.33e-05	0.000779	CbGpPWpGaD
Lamivudine—Urticaria—Epirubicin—uterine cancer	6.32e-05	0.000411	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—uterine cancer	6.3e-05	0.00041	CcSEcCtD
Lamivudine—Pain—Doxorubicin—uterine cancer	6.3e-05	0.00041	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—uterine cancer	6.29e-05	0.000409	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—uterine cancer	6.29e-05	0.000409	CcSEcCtD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.21e-05	0.000765	CbGpPWpGaD
Lamivudine—DCK—Metabolism—POLD1—uterine cancer	6.18e-05	0.000761	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.15e-05	0.000757	CbGpPWpGaD
Lamivudine—Feeling abnormal—Doxorubicin—uterine cancer	6.07e-05	0.000395	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—uterine cancer	6.02e-05	0.000392	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—IRF1—uterine cancer	5.96e-05	0.000734	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.91e-05	0.000727	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—MTHFR—uterine cancer	5.9e-05	0.000726	CbGpPWpGaD
Lamivudine—Hypersensitivity—Epirubicin—uterine cancer	5.86e-05	0.000381	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—uterine cancer	5.85e-05	0.00038	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—uterine cancer	5.82e-05	0.000379	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—uterine cancer	5.82e-05	0.000379	CcSEcCtD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.8e-05	0.000715	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKR1C1—uterine cancer	5.78e-05	0.000712	CbGpPWpGaD
Lamivudine—Asthenia—Epirubicin—uterine cancer	5.71e-05	0.000371	CcSEcCtD
Lamivudine—ABCC4—Ectoderm Differentiation—CTNNB1—uterine cancer	5.66e-05	0.000697	CbGpPWpGaD
Lamivudine—Pruritus—Epirubicin—uterine cancer	5.63e-05	0.000366	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—MTHFR—uterine cancer	5.48e-05	0.000675	CbGpPWpGaD
Lamivudine—Diarrhoea—Epirubicin—uterine cancer	5.45e-05	0.000354	CcSEcCtD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	5.44e-05	0.00067	CbGpPWpGaD
Lamivudine—Hypersensitivity—Doxorubicin—uterine cancer	5.43e-05	0.000353	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—uterine cancer	5.28e-05	0.000344	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—uterine cancer	5.26e-05	0.000342	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—uterine cancer	5.21e-05	0.000339	CcSEcCtD
Lamivudine—DCK—Metabolism—RRM2—uterine cancer	5.16e-05	0.000635	CbGpPWpGaD
Lamivudine—Vomiting—Epirubicin—uterine cancer	5.06e-05	0.000329	CcSEcCtD
Lamivudine—NME1—Metabolism—STK11—uterine cancer	5.06e-05	0.000623	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CYP19A1—uterine cancer	5.06e-05	0.000623	CbGpPWpGaD
Lamivudine—Diarrhoea—Doxorubicin—uterine cancer	5.04e-05	0.000328	CcSEcCtD
Lamivudine—Rash—Epirubicin—uterine cancer	5.02e-05	0.000326	CcSEcCtD
Lamivudine—NME2—Metabolism—MTHFR—uterine cancer	5.01e-05	0.000618	CbGpPWpGaD
Lamivudine—Dermatitis—Epirubicin—uterine cancer	5.01e-05	0.000326	CcSEcCtD
Lamivudine—DCK—Metabolism—DCN—uterine cancer	5e-05	0.000616	CbGpPWpGaD
Lamivudine—Headache—Epirubicin—uterine cancer	4.99e-05	0.000324	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—AKR1B1—uterine cancer	4.98e-05	0.000613	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—STAR—uterine cancer	4.98e-05	0.000613	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SRD5A2—uterine cancer	4.96e-05	0.00061	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NDUFB11—uterine cancer	4.96e-05	0.00061	CbGpPWpGaD
Lamivudine—Dizziness—Doxorubicin—uterine cancer	4.87e-05	0.000317	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.83e-05	0.000595	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.82e-05	0.000593	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	4.79e-05	0.00059	CbGpPWpGaD
Lamivudine—Nausea—Epirubicin—uterine cancer	4.73e-05	0.000307	CcSEcCtD
Lamivudine—DCK—Metabolism—CYP11A1—uterine cancer	4.72e-05	0.000581	CbGpPWpGaD
Lamivudine—Vomiting—Doxorubicin—uterine cancer	4.68e-05	0.000305	CcSEcCtD
Lamivudine—Rash—Doxorubicin—uterine cancer	4.64e-05	0.000302	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—uterine cancer	4.64e-05	0.000302	CcSEcCtD
Lamivudine—Headache—Doxorubicin—uterine cancer	4.61e-05	0.0003	CcSEcCtD
Lamivudine—ABCC1—Disease—AKR1B10—uterine cancer	4.6e-05	0.000567	CbGpPWpGaD
Lamivudine—PGK1—Disease—ERBB2—uterine cancer	4.59e-05	0.000566	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKR1B1—uterine cancer	4.57e-05	0.000563	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—STAR—uterine cancer	4.57e-05	0.000563	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.55e-05	0.00056	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.52e-05	0.000557	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKR1C3—uterine cancer	4.45e-05	0.000548	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.44e-05	0.000547	CbGpPWpGaD
Lamivudine—Nausea—Doxorubicin—uterine cancer	4.37e-05	0.000284	CcSEcCtD
Lamivudine—ABCG2—Metabolism—SRD5A2—uterine cancer	4.36e-05	0.000537	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NDUFB11—uterine cancer	4.36e-05	0.000537	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NDUFB11—uterine cancer	4.32e-05	0.000532	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SRD5A2—uterine cancer	4.32e-05	0.000532	CbGpPWpGaD
Lamivudine—PGK1—Disease—CDKN1B—uterine cancer	4.25e-05	0.000524	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.21e-05	0.000518	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.04e-05	0.000497	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTEN—uterine cancer	4.02e-05	0.000496	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTEN—uterine cancer	4.02e-05	0.000496	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTEN—uterine cancer	4.02e-05	0.000496	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NDUFB11—uterine cancer	4.02e-05	0.000495	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SRD5A2—uterine cancer	4.02e-05	0.000495	CbGpPWpGaD
Lamivudine—PGK1—Disease—CTNNB1—uterine cancer	4.02e-05	0.000495	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTEN—uterine cancer	3.92e-05	0.000482	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—POLD1—uterine cancer	3.9e-05	0.000481	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—EP300—uterine cancer	3.84e-05	0.000473	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—EP300—uterine cancer	3.84e-05	0.000473	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—EP300—uterine cancer	3.84e-05	0.000473	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RNF43—uterine cancer	3.81e-05	0.00047	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	3.8e-05	0.000468	CbGpPWpGaD
Lamivudine—NME1—Metabolism—MTHFR—uterine cancer	3.8e-05	0.000468	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.76e-05	0.000464	CbGpPWpGaD
Lamivudine—PGK1—Disease—EP300—uterine cancer	3.74e-05	0.00046	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKR1C1—uterine cancer	3.65e-05	0.00045	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.64e-05	0.000448	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.62e-05	0.000446	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—POLD1—uterine cancer	3.59e-05	0.000442	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKR1B1—uterine cancer	3.58e-05	0.000441	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—STAR—uterine cancer	3.58e-05	0.000441	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.57e-05	0.000439	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.54e-05	0.000436	CbGpPWpGaD
Lamivudine—PGK1—Disease—NRAS—uterine cancer	3.5e-05	0.00043	CbGpPWpGaD
Lamivudine—DCK—Metabolism—STK11—uterine cancer	3.47e-05	0.000427	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP19A1—uterine cancer	3.47e-05	0.000427	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	3.42e-05	0.000421	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKR1C1—uterine cancer	3.36e-05	0.000413	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTEN—uterine cancer	3.28e-05	0.000404	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—RRM2—uterine cancer	3.26e-05	0.000401	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—DCN—uterine cancer	3.16e-05	0.000389	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKR1B1—uterine cancer	3.15e-05	0.000388	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—STAR—uterine cancer	3.15e-05	0.000388	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKR1C1—uterine cancer	3.14e-05	0.000387	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—EP300—uterine cancer	3.13e-05	0.000385	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKR1B1—uterine cancer	3.12e-05	0.000384	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—STAR—uterine cancer	3.12e-05	0.000384	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	3.09e-05	0.00038	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTEN—uterine cancer	3.05e-05	0.000376	CbGpPWpGaD
Lamivudine—PGK1—Disease—KRAS—uterine cancer	3.01e-05	0.00037	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—RRM2—uterine cancer	2.99e-05	0.000368	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP11A1—uterine cancer	2.98e-05	0.000367	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—EP300—uterine cancer	2.91e-05	0.000358	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKR1B1—uterine cancer	2.91e-05	0.000358	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—STAR—uterine cancer	2.91e-05	0.000358	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—DCN—uterine cancer	2.9e-05	0.000358	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PIK3CA—uterine cancer	2.84e-05	0.00035	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PIK3CA—uterine cancer	2.84e-05	0.00035	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PIK3CA—uterine cancer	2.84e-05	0.00035	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—POLD1—uterine cancer	2.81e-05	0.000346	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKR1C3—uterine cancer	2.81e-05	0.000346	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTEN—uterine cancer	2.79e-05	0.000344	CbGpPWpGaD
Lamivudine—PGK1—Disease—PIK3CA—uterine cancer	2.76e-05	0.00034	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP11A1—uterine cancer	2.74e-05	0.000337	CbGpPWpGaD
Lamivudine—ABCC1—Disease—DCN—uterine cancer	2.72e-05	0.000335	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.7e-05	0.000332	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.67e-05	0.000329	CbGpPWpGaD
Lamivudine—NME2—Metabolism—EP300—uterine cancer	2.66e-05	0.000328	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKR1C1—uterine cancer	2.63e-05	0.000324	CbGpPWpGaD
Lamivudine—DCK—Metabolism—MTHFR—uterine cancer	2.61e-05	0.000321	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKR1C3—uterine cancer	2.58e-05	0.000318	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—uterine cancer	2.56e-05	0.000315	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—POLD1—uterine cancer	2.47e-05	0.000305	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—POLD1—uterine cancer	2.45e-05	0.000302	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKR1C3—uterine cancer	2.42e-05	0.000298	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NDUFB11—uterine cancer	2.36e-05	0.00029	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SRD5A2—uterine cancer	2.36e-05	0.00029	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HMGA1—uterine cancer	2.36e-05	0.00029	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—RRM2—uterine cancer	2.34e-05	0.000289	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—uterine cancer	2.32e-05	0.000286	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—uterine cancer	2.32e-05	0.000286	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—uterine cancer	2.32e-05	0.000286	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKR1C1—uterine cancer	2.31e-05	0.000285	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—uterine cancer	2.31e-05	0.000285	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKR1C1—uterine cancer	2.29e-05	0.000282	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—POLD1—uterine cancer	2.28e-05	0.000281	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—DCN—uterine cancer	2.28e-05	0.00028	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.28e-05	0.00028	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—uterine cancer	2.26e-05	0.000278	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—STK11—uterine cancer	2.19e-05	0.00027	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP19A1—uterine cancer	2.19e-05	0.00027	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.18e-05	0.000269	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FBXW7—uterine cancer	2.16e-05	0.000265	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—uterine cancer	2.15e-05	0.000265	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP11A1—uterine cancer	2.14e-05	0.000264	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKR1C1—uterine cancer	2.14e-05	0.000263	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTEN—uterine cancer	2.11e-05	0.00026	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—RRM2—uterine cancer	2.06e-05	0.000254	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—RRM2—uterine cancer	2.04e-05	0.000251	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKR1C3—uterine cancer	2.03e-05	0.000249	CbGpPWpGaD
Lamivudine—NME1—Metabolism—EP300—uterine cancer	2.02e-05	0.000248	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP19A1—uterine cancer	2.01e-05	0.000248	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—STK11—uterine cancer	2.01e-05	0.000248	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—DCN—uterine cancer	2e-05	0.000247	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—DCN—uterine cancer	1.98e-05	0.000244	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.98e-05	0.000244	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—uterine cancer	1.97e-05	0.000242	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.94e-05	0.000239	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—RRM2—uterine cancer	1.9e-05	0.000234	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—uterine cancer	1.89e-05	0.000233	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.89e-05	0.000233	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP11A1—uterine cancer	1.89e-05	0.000232	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP11A1—uterine cancer	1.87e-05	0.00023	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—EP300—uterine cancer	1.86e-05	0.000229	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—DCN—uterine cancer	1.85e-05	0.000227	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.83e-05	0.000226	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	1.81e-05	0.000223	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.8e-05	0.000222	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKR1C3—uterine cancer	1.78e-05	0.000219	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKR1C3—uterine cancer	1.76e-05	0.000217	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—uterine cancer	1.76e-05	0.000217	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—uterine cancer	1.76e-05	0.000216	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—uterine cancer	1.74e-05	0.000214	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP11A1—uterine cancer	1.74e-05	0.000214	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.73e-05	0.000213	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—STAR—uterine cancer	1.71e-05	0.00021	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.71e-05	0.00021	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN2B—uterine cancer	1.69e-05	0.000208	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.69e-05	0.000208	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MTHFR—uterine cancer	1.65e-05	0.000203	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKR1C3—uterine cancer	1.64e-05	0.000202	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.61e-05	0.000198	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—uterine cancer	1.61e-05	0.000198	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—STK11—uterine cancer	1.58e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP19A1—uterine cancer	1.58e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SMAD3—uterine cancer	1.54e-05	0.00019	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.52e-05	0.000188	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTHFR—uterine cancer	1.51e-05	0.000186	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—uterine cancer	1.5e-05	0.000185	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—uterine cancer	1.49e-05	0.000184	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—uterine cancer	1.49e-05	0.000183	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.48e-05	0.000182	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR2—uterine cancer	1.47e-05	0.000181	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—uterine cancer	1.45e-05	0.000179	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—uterine cancer	1.42e-05	0.000174	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.41e-05	0.000174	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—STK11—uterine cancer	1.39e-05	0.000171	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP19A1—uterine cancer	1.39e-05	0.000171	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—uterine cancer	1.39e-05	0.000171	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—uterine cancer	1.38e-05	0.00017	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.38e-05	0.00017	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—STK11—uterine cancer	1.37e-05	0.000169	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP19A1—uterine cancer	1.37e-05	0.000169	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—POLD1—uterine cancer	1.34e-05	0.000165	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.33e-05	0.000164	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—uterine cancer	1.33e-05	0.000164	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.3e-05	0.00016	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—STK11—uterine cancer	1.28e-05	0.000158	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP19A1—uterine cancer	1.28e-05	0.000158	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—uterine cancer	1.27e-05	0.000157	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.25e-05	0.000154	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—uterine cancer	1.22e-05	0.00015	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.19e-05	0.000147	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—uterine cancer	1.19e-05	0.000146	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.15e-05	0.000142	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—uterine cancer	1.12e-05	0.000139	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RRM2—uterine cancer	1.12e-05	0.000137	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—DCN—uterine cancer	1.08e-05	0.000133	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.04e-05	0.000129	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—uterine cancer	1.04e-05	0.000128	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—uterine cancer	1.03e-05	0.000127	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—uterine cancer	1.02e-05	0.000126	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP11A1—uterine cancer	1.02e-05	0.000126	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.72e-06	0.00012	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C3—uterine cancer	9.63e-06	0.000119	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—uterine cancer	9.62e-06	0.000118	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—uterine cancer	9.24e-06	0.000114	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—uterine cancer	9.16e-06	0.000113	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—uterine cancer	8.73e-06	0.000108	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—uterine cancer	8.55e-06	0.000105	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—uterine cancer	8.42e-06	0.000104	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—uterine cancer	8.36e-06	0.000103	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—uterine cancer	8.08e-06	9.95e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—uterine cancer	8.03e-06	9.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—uterine cancer	7.88e-06	9.7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—uterine cancer	7.51e-06	9.25e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP19A1—uterine cancer	7.51e-06	9.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—STK11—uterine cancer	7.51e-06	9.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—uterine cancer	7.03e-06	8.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—uterine cancer	6.6e-06	8.12e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—uterine cancer	6.46e-06	7.96e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—uterine cancer	6.29e-06	7.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—uterine cancer	6.05e-06	7.45e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—uterine cancer	5.94e-06	7.31e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—uterine cancer	5.8e-06	7.15e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—uterine cancer	5.74e-06	7.07e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—uterine cancer	5.64e-06	6.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—uterine cancer	5.56e-06	6.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—uterine cancer	5.53e-06	6.82e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—uterine cancer	5.48e-06	6.74e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—uterine cancer	5.35e-06	6.59e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—uterine cancer	5.28e-06	6.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—uterine cancer	5.14e-06	6.33e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—uterine cancer	5.11e-06	6.29e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—uterine cancer	4.85e-06	5.97e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—uterine cancer	4.65e-06	5.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—uterine cancer	4.54e-06	5.59e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—uterine cancer	4.09e-06	5.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—uterine cancer	4.05e-06	4.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—uterine cancer	3.8e-06	4.68e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—uterine cancer	3.78e-06	4.65e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—uterine cancer	3.34e-06	4.12e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—uterine cancer	3.31e-06	4.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—uterine cancer	3.14e-06	3.86e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—uterine cancer	3.09e-06	3.8e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—uterine cancer	2.99e-06	3.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.21e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—uterine cancer	1.81e-06	2.23e-05	CbGpPWpGaD
